These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 214379)

  • 1. [Possible non-immunologic mechanism in atopic bronchial asthma].
    Kersten W; Stevens E; Hoek GT
    Fortschr Med; 1978 Dec; 96(47-48):2349-52. PubMed ID: 214379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-receptor decrease in bronchial asthma.
    Oehling A; Sanz ML; Gamboa PM
    Allerg Immunol (Paris); 1991 Sep; 23(7):285-8. PubMed ID: 1660276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bronchial asthma and bronchial reactivity].
    Abrosimov VN
    Ter Arkh; 1981; 53(4):135-41. PubMed ID: 6266063
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of the adrenergic system in allergy and bronchial hyperreactivity.
    Koëter GH; Meurs H; Kauffman HF; de Vries K
    Eur J Respir Dis Suppl; 1982; 121():72-8. PubMed ID: 6290251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Content of cyclic nucleotides in blood plasma of patients with bronchial asthma].
    Kotova SA; Ialkut SI
    Vopr Med Khim; 1981; 27(2):201-3. PubMed ID: 6269297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of the lymphocyte beta-adrenoceptor system in patients with allergic bronchial asthma.
    Meurs H; Koëter GH; de Vries K; Kauffman HF
    Eur J Respir Dis Suppl; 1984; 135():47-61. PubMed ID: 6329809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in cyclic adenosine monophosphate metabolism in human bronchial asthma. I. Leukocyte responsiveness to -adrenergic agents.
    Parker CW; Smith JW
    J Clin Invest; 1973 Jan; 52(1):48-59. PubMed ID: 4404909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Variations of plasmatic cyclic nucleotides in the asthmatic patient (cyclic adenosine monophosphate and cyclic guanosine monophosphate) (author's transl)].
    Clauzel AM; Calvayrac P; Michel FB
    Poumon Coeur; 1980; 36(5):295-302. PubMed ID: 6256723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Suppression of non-specific bronchial hyperreactivity by DSCG (Disodium cromoglycate) and ipratropium bromide (author's transl)].
    Götz M; Popow C
    Wien Klin Wochenschr; 1980 Sep; 92(18):638-41. PubMed ID: 6451084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-atopic asthma in children is related to maternal bronchial hyperreactivity.
    Ozdemir C; Ceyhan BB; Yazi D; Eifan AO; Yesil O; Bahceciler NN; Barlan IB
    Pediatr Allergy Immunol; 2008 May; 19(3):248-54. PubMed ID: 18397409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease of beta-receptors after the antigen-specific bronchial provocation test in bronchial asthma.
    Gamboa PM; de la Cuesta CG; Sanz ML; García BE; Oehling A
    Allergol Immunopathol (Madr); 1990; 18(3):115-9. PubMed ID: 2174641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changed equilibrium between the sympathetic-adenyl cyclase-cyclic AMP-PGE system and the cholinergic-guanyl cyclase-cyclic GMP-PGF2 alpha system as a pathogenetic mechanism of bronchial asthma].
    Accardo G; Pazzi A
    G Clin Med; 1980 Jun; 61(6):444-8. PubMed ID: 6108890
    [No Abstract]   [Full Text] [Related]  

  • 13. [Disorders of cellular regulation systems as a basis for changed bronchial reactivity in bronchial asthma].
    Fedoseev GB; Zhikharev SS; Mineev VV; Morozova NN; Subbotina TF
    Ter Arkh; 1984; 56(12):71-5. PubMed ID: 6098046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complement system in patients with IgE related and non IgE related bronchial asthma].
    Obtułowicz K; Kapusta M; Antoszczyk G
    Przegl Lek; 2002; 59(6):430-2. PubMed ID: 12418280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of the adenylcyclase--cycl AMP system in the histamine liberation during the immune reaction of type I].
    Marone G
    Recenti Prog Med; 1976 Nov; 61(5):662-83. PubMed ID: 66733
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary cyclic adenosine 3',5'-monophosphate (cAMP) and cyclic guanosine 3',5'-monophosphate (cGMP) in asthmatic and normal children.
    König P; Carpenter M; White AA
    Eur J Respir Dis; 1980 Aug; 61(4):218-26. PubMed ID: 6258958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of beta-adrenoceptor at different stages of bronchial asthma.
    Gao H; Xue Q; Lin Y; Wang L; Zhu G; Zhao Q; Chen Y
    Chin Med J (Engl); 2001 Dec; 114(12):1317-9. PubMed ID: 11793862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bronchial asthma. Treatment in relation to physiopathology and bronchial hyperreactivity].
    Hvidsten D
    Tidsskr Nor Laegeforen; 1989 Oct; 109(30):3098-101. PubMed ID: 2815041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of theophylline, prednisolone and sleep withdrawal on airway obstruction and urinary cyclic AMP/cyclic GMP excretion of asthmatic children with and without nocturnal asthma.
    Reinhardt D; Schuhmacher P; Fox A; Stemmann EA; Wegner F
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):399-404. PubMed ID: 6256299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in the beta-adrenergic system in bronchial asthma induced by terbutaline.
    Koëter GH; Meurs H; Kauffman HF; de Monchy JG; Sluiter HJ; de Vries K
    Agents Actions Suppl; 1983; 13():259-64. PubMed ID: 6307021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.